Psychiatry and Neurology, Neurology · Albuquerque, NM
NPI
1881685303
Since 2005
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
Msc10 5620 1 University of Nm, The University of New Mexico, Dept of Neurology
Albuquerque, NM, 87131
Phone (505) 272-3160
Groups this clinician bills Medicare through
Medicare paid, 2024
$40K
539 services
Medicare patients, 2024
223
Average age 73
Drug cost, 2024
$372K
2,053 prescriptions
Company payments, 2024
$30.14
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Amanda L Deligtisch was code 99214 (office e&m - established), 198 times for 137 patients. In total Amanda L Deligtisch billed 539 services in 19 codes, and Medicare paid $40K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-02-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 198 | 137 | $66.67 | $13K |
| 99215 Office E&M - Established | Office | 62 | 51 | $110.36 | $6,842 |
| 64616 Musculoskeletal | Office | 52 | 15 | $100.53 | $5,228 |
| 64612 Musculoskeletal | Office | 42 | 11 | $121.97 | $5,123 |
| 99205 Office E&M - New | Office | 29 | 29 | $146.95 | $4,262 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 27 | 18 | $25.76 | $695 |
| 99213 Office E&M - Established | Office | 24 | 20 | $49.14 | $1,179 |
| 95983 Electrical Nerve Conductivity | Office | 19 | 14 | $37.74 | $717 |
| 99212 Office E&M - Established | Office | 18 | 13 | $21.01 | $378 |
| 95970 Electrical Nerve Conductivity | Office | 18 | 15 | $14.14 | $255 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 17 | 15 | $13.58 | $231 |
By year: 2022 $45K for 612 services; 2023 $44K for 609 services; 2024 $40K for 539 services.
Medicare prescription drug claims, 2024
In 2024, the drug Amanda L Deligtisch prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 579 prescriptions and refills. In total Amanda L Deligtisch wrote 2,053 Medicare prescriptions that cost $372K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 579 | 1,391 | 162 | $23K |
| Amantadine Amantadine Hcl | 176 | 350 | 43 | $16K |
| Clonazepam Generic | 159 | 159 | 24 | $1,962 |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 79 | 205 | 23 | $2,800 |
| Neupro Rotigotine | 74 | 144 | 21 | $114K |
| Gabapentin Generic | 64 | 128 | 20 | $1,409 |
| Memantine Hcl Generic | 55 | 139 | 17 | $2,322 |
| Lorazepam Generic | 53 | 57 | 12 | $944 |
| Carbidopa Generic | 49 | 73 | Under 11 | $21K |
| Sertraline Hcl Generic | 48 | 120 | 15 | $729 |
| Mirtazapine Generic | 45 | 99 | 15 | $760 |
| Baclofen Generic | 45 | 59 | 11 | $571 |
| Primidone Generic | 41 | 91 | Under 11 | $1,982 |
| Diazepam Generic | 37 | 42 | Under 11 | $111 |
| Quetiapine Fumarate Generic | 36 | 64 | Under 11 | $316 |
Brand drugs: 163 claims; generic drugs: 1,890 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Amanda L Deligtisch $30.14 ($30.14 in general payments such as food, travel and fees) from 1 company. The largest payer was Abbvie Inc. with $30.14.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 1 | $30.14 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.